Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 603 for hematology

Edit search filters
  1. Outcomes Of Regional Consensus Treatment Guidelines For Management Of Surgery, Invasive Procedures And Control Of Hemorrhages In Patients With Bleeding Disorders; And Management Of Thrombosis And Thromboprophylaxis In Patients With Thrombophilia

    Rochester, MN

  2. Validation Of A Flow-micro Immunomagnetic System For Rare Cell Isolation From Peripheral Blood

    Rochester, MN

  3. A Phase I/II Study Of AZD0466 As Monotherapy Or In Combination With Anticancer Agents In Advanced Non-Hodgkin Lymphoma

    Rochester, MN

  4. A Study Of Acceptance And Commitment Therapy In Patients With Myeloproliferative Neoplasms

    Scottsdale/Phoenix, AZ

  5. A Study Of Oral LOXO-305 In Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Or Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. DALY II USA/ MB-CART2019.1 For DLBCL

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Evaluating Safety And Efficacy Of Venetoclax In Combination With Azacitidine Versus Standard Of Care After Allogeneic Stem Cell Transplantation (SCT) In Participants With Acute Myeloid Leukemia (AML)

    Jacksonville, FL, Rochester, MN

  8. Early Detection of Hemodynamic Decompensation in Humans

    Rochester, MN

  9. A Phase 1/​2 Study Of STP938 For Adult Subjects With Relapsed/​Refractory B-Cell And T-Cell Lymphomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia

    Rochester, MN

.

Mayo Clinic Footer